Surmodics, Inc. (DELISTED) (SRDX:DL)
42.98
0.00 (0.00%)
USD |
NASDAQ |
Nov 28, 16:00
Surmodics Shareholders Equity (Quarterly): 111.31M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 598.36M |
| Atossa Therapeutics, Inc. | 49.79M |
| Abeona Therapeutics, Inc. | 171.23M |
| Kiora Pharmaceuticals, Inc. | 22.41M |
| Intellia Therapeutics, Inc. | 748.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 169.82M |
| Total Liabilities (Quarterly) | 58.51M |
| Debt to Equity Ratio | 0.2927 |
| Current Ratio | 3.909 |
| Net Debt Paydown Yield | 0.05% |